The FDA announced a nationwide recall of private label acetaminophen products sold by CVS, Eckerd, Wal-Mart, Kmart, and a number of other chain pharmaciesa move prompted by safety issues that arose during the manufacturing process.
The generic manufacturer of the OTC analgesics, Michigan-based Perrigo Co, voluntarily recalled 383 lots of acetaminophen 500-mg caplets as a result of small metal fragments found in a small number of these caplets. Although the caplets were destined for distribution under various store brands throughout the country, FDA officials said they received no patient complaints or reports of illness or injuries associated with the recalled products. The agency described the probability of serious adverse health consequences as "remote" but acknowledged that, "if a consumer were to swallow an affected caplet, it could result in minor stomach discomfort and/or possible cuts to the mouth or throat."
Visit ePharmacy Times at www.pharmacytimes.com/articleNewsletter.cfm?ID=4022 for a related story on the recall.
5 Studies That Shaped HIV Treatment That Every Pharmacist Should Know
Over the years, a number of landmark clinical studies in the field of virology have been published, shaping how we treat many infectious diseases today.
News from the year's biggest meetings
Clinical features with downloadable PDFs